Home  |  Contact

Cellosaurus HKESC-1/cis (CVCL_S525)

[Text version]

Cell line name HKESC-1/cis
Accession CVCL_S525
Resource Identification Initiative To cite this cell line use: HKESC-1/cis (RRID:CVCL_S525)
Comments Population: Chinese.
Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
Disease Esophageal squamous cell carcinoma (NCIt: C4024)
Squamous cell carcinoma of the esophagus (ORDO: Orphanet_99977)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_D568 (HKESC-1)
Sex of cell Male
Age at sampling 47Y
Category Cancer cell line
Publications

PubMed=21177414; DOI=10.1124/mol.110.069393
Yu L., Chen M., Li Z., Wen J., Fu J., Guo D., Jiang Y., Wu S., Cho C.H., Liu S.
Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
Mol. Pharmacol. 79:608-617(2011)

Cross-references
Other Wikidata; Q54889767
Entry history
Entry creation03-Feb-2014
Last entry update12-Mar-2020
Version number8